Absorption and metabolism of vitamin D in health and in gastrointestinal tract diseases
Over the past decades, we have witnessed many remarkable advances in understanding the impact of vitamin D on human health. There is an exponential growth of new data covering both the fundamental biology of vitamin D and the clinical implications of deficiency and the effects of vitamin D supplemen...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
E. A. Pigarova [verfasserIn] L. К. Dzeranova [verfasserIn] D. A. Yatsenko [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch ; Russisch |
| Erschienen: |
2022 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
In: Ожирение и метаболизм ; 19(2022), 1, Seite 123-133 volume:19 ; year:2022 ; number:1 ; pages:123-133 |
|---|
| Links: |
Link aufrufen |
|---|
| DOI / URN: |
10.14341/omet12835 |
|---|
| Katalog-ID: |
DOAJ034236430 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ034236430 | ||
| 003 | DE-627 | ||
| 005 | 20240413141250.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.14341/omet12835 |2 doi | |
| 035 | |a (DE-627)DOAJ034236430 | ||
| 035 | |a (DE-599)DOAJce55a423258d41a4b6d1bfcebd9ca184 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a rus | ||
| 050 | 0 | |a QP1-981 | |
| 050 | 0 | |a QD415-436 | |
| 100 | 0 | |a E. A. Pigarova |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Absorption and metabolism of vitamin D in health and in gastrointestinal tract diseases |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Over the past decades, we have witnessed many remarkable advances in understanding the impact of vitamin D on human health. There is an exponential growth of new data covering both the fundamental biology of vitamin D and the clinical implications of deficiency and the effects of vitamin D supplementation. This literature review has been prepared to combine and interpret the current scientific evidence on the mechanisms of vitamin D absorption, with a focus on vitamin D absorption through the apical membrane of enterocytes in various pathologies of the gastrointestinal tract. Reviewed studies have identified some distinctive aspects of vitamin D bioavailability that should be considered in the treatment or prevention of vitamin D deficiency in patients with malabsorption syndromes, especially in the active phase of the disease. Moreover, recent in vivo experiments and in vitro studies have demonstrated that vitamin D absorption is not a simple diffusion process as previously thought, but rather a mechanism that also involves multiple membrane transporters. Maintaining or improving vitamin D intake through diet or increased sun exposure is problematic, so oral supplementation may be an effective and safe approach to improving vitamin D status. Vitamin D3 is the recommended form for both prevention and treatment of vitamin D deficiency, which is associated with more stable pharmacokinetics. Vitamin D absorption is improved when vitamin D is taken with a small amount of fat-containing food and medium chain triglycerides. In malabsorption syndromes, it is optimal to increase the general population doses of vitamin D by 2–3 times both for prevention and for the treatment of deficiency and insufficiency. While vitamin D deficiency is more common among people with gastrointestinal disease, data have not been able to establish whether the relationship is causal or the result of intestinal inflammation and malabsorption syndrome. However, owing to the understanding of the mechanisms of action of vitamin D, there is evidence that its deficiency can be directly related to the severity of the disease, and partly to the etiology or pathogenesis of the disease itself. | ||
| 650 | 4 | |a cholecalciferol | |
| 650 | 4 | |a vitamin d | |
| 650 | 4 | |a medium chain triglycerides | |
| 650 | 4 | |a absorption | |
| 650 | 4 | |a malabsorption syndrome | |
| 650 | 4 | |a intestine | |
| 650 | 4 | |a vitaminkid3 | |
| 653 | 0 | |a Physiology | |
| 653 | 0 | |a Biochemistry | |
| 700 | 0 | |a L. К. Dzeranova |e verfasserin |4 aut | |
| 700 | 0 | |a D. A. Yatsenko |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Ожирение и метаболизм |g 19(2022), 1, Seite 123-133 |
| 773 | 1 | 8 | |g volume:19 |g year:2022 |g number:1 |g pages:123-133 |
| 856 | 4 | 0 | |u https://doi.org/10.14341/omet12835 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/ce55a423258d41a4b6d1bfcebd9ca184 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.omet-endojournals.ru/jour/article/view/12835 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2071-8713 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2306-5524 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2022 |e 1 |h 123-133 | ||
| author_variant |
e a p eap l к d lкd d a y day |
|---|---|
| matchkey_str |
eapigarovaldzeranovadayatsenko:2022----:bopinnmtblsovtmnihatadnaton |
| hierarchy_sort_str |
2022 |
| callnumber-subject-code |
QP |
| publishDate |
2022 |
| allfields |
10.14341/omet12835 doi (DE-627)DOAJ034236430 (DE-599)DOAJce55a423258d41a4b6d1bfcebd9ca184 DE-627 ger DE-627 rakwb eng rus QP1-981 QD415-436 E. A. Pigarova verfasserin aut Absorption and metabolism of vitamin D in health and in gastrointestinal tract diseases 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Over the past decades, we have witnessed many remarkable advances in understanding the impact of vitamin D on human health. There is an exponential growth of new data covering both the fundamental biology of vitamin D and the clinical implications of deficiency and the effects of vitamin D supplementation. This literature review has been prepared to combine and interpret the current scientific evidence on the mechanisms of vitamin D absorption, with a focus on vitamin D absorption through the apical membrane of enterocytes in various pathologies of the gastrointestinal tract. Reviewed studies have identified some distinctive aspects of vitamin D bioavailability that should be considered in the treatment or prevention of vitamin D deficiency in patients with malabsorption syndromes, especially in the active phase of the disease. Moreover, recent in vivo experiments and in vitro studies have demonstrated that vitamin D absorption is not a simple diffusion process as previously thought, but rather a mechanism that also involves multiple membrane transporters. Maintaining or improving vitamin D intake through diet or increased sun exposure is problematic, so oral supplementation may be an effective and safe approach to improving vitamin D status. Vitamin D3 is the recommended form for both prevention and treatment of vitamin D deficiency, which is associated with more stable pharmacokinetics. Vitamin D absorption is improved when vitamin D is taken with a small amount of fat-containing food and medium chain triglycerides. In malabsorption syndromes, it is optimal to increase the general population doses of vitamin D by 2–3 times both for prevention and for the treatment of deficiency and insufficiency. While vitamin D deficiency is more common among people with gastrointestinal disease, data have not been able to establish whether the relationship is causal or the result of intestinal inflammation and malabsorption syndrome. However, owing to the understanding of the mechanisms of action of vitamin D, there is evidence that its deficiency can be directly related to the severity of the disease, and partly to the etiology or pathogenesis of the disease itself. cholecalciferol vitamin d medium chain triglycerides absorption malabsorption syndrome intestine vitaminkid3 Physiology Biochemistry L. К. Dzeranova verfasserin aut D. A. Yatsenko verfasserin aut In Ожирение и метаболизм 19(2022), 1, Seite 123-133 volume:19 year:2022 number:1 pages:123-133 https://doi.org/10.14341/omet12835 kostenfrei https://doaj.org/article/ce55a423258d41a4b6d1bfcebd9ca184 kostenfrei https://www.omet-endojournals.ru/jour/article/view/12835 kostenfrei https://doaj.org/toc/2071-8713 Journal toc kostenfrei https://doaj.org/toc/2306-5524 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 19 2022 1 123-133 |
| spelling |
10.14341/omet12835 doi (DE-627)DOAJ034236430 (DE-599)DOAJce55a423258d41a4b6d1bfcebd9ca184 DE-627 ger DE-627 rakwb eng rus QP1-981 QD415-436 E. A. Pigarova verfasserin aut Absorption and metabolism of vitamin D in health and in gastrointestinal tract diseases 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Over the past decades, we have witnessed many remarkable advances in understanding the impact of vitamin D on human health. There is an exponential growth of new data covering both the fundamental biology of vitamin D and the clinical implications of deficiency and the effects of vitamin D supplementation. This literature review has been prepared to combine and interpret the current scientific evidence on the mechanisms of vitamin D absorption, with a focus on vitamin D absorption through the apical membrane of enterocytes in various pathologies of the gastrointestinal tract. Reviewed studies have identified some distinctive aspects of vitamin D bioavailability that should be considered in the treatment or prevention of vitamin D deficiency in patients with malabsorption syndromes, especially in the active phase of the disease. Moreover, recent in vivo experiments and in vitro studies have demonstrated that vitamin D absorption is not a simple diffusion process as previously thought, but rather a mechanism that also involves multiple membrane transporters. Maintaining or improving vitamin D intake through diet or increased sun exposure is problematic, so oral supplementation may be an effective and safe approach to improving vitamin D status. Vitamin D3 is the recommended form for both prevention and treatment of vitamin D deficiency, which is associated with more stable pharmacokinetics. Vitamin D absorption is improved when vitamin D is taken with a small amount of fat-containing food and medium chain triglycerides. In malabsorption syndromes, it is optimal to increase the general population doses of vitamin D by 2–3 times both for prevention and for the treatment of deficiency and insufficiency. While vitamin D deficiency is more common among people with gastrointestinal disease, data have not been able to establish whether the relationship is causal or the result of intestinal inflammation and malabsorption syndrome. However, owing to the understanding of the mechanisms of action of vitamin D, there is evidence that its deficiency can be directly related to the severity of the disease, and partly to the etiology or pathogenesis of the disease itself. cholecalciferol vitamin d medium chain triglycerides absorption malabsorption syndrome intestine vitaminkid3 Physiology Biochemistry L. К. Dzeranova verfasserin aut D. A. Yatsenko verfasserin aut In Ожирение и метаболизм 19(2022), 1, Seite 123-133 volume:19 year:2022 number:1 pages:123-133 https://doi.org/10.14341/omet12835 kostenfrei https://doaj.org/article/ce55a423258d41a4b6d1bfcebd9ca184 kostenfrei https://www.omet-endojournals.ru/jour/article/view/12835 kostenfrei https://doaj.org/toc/2071-8713 Journal toc kostenfrei https://doaj.org/toc/2306-5524 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 19 2022 1 123-133 |
| allfields_unstemmed |
10.14341/omet12835 doi (DE-627)DOAJ034236430 (DE-599)DOAJce55a423258d41a4b6d1bfcebd9ca184 DE-627 ger DE-627 rakwb eng rus QP1-981 QD415-436 E. A. Pigarova verfasserin aut Absorption and metabolism of vitamin D in health and in gastrointestinal tract diseases 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Over the past decades, we have witnessed many remarkable advances in understanding the impact of vitamin D on human health. There is an exponential growth of new data covering both the fundamental biology of vitamin D and the clinical implications of deficiency and the effects of vitamin D supplementation. This literature review has been prepared to combine and interpret the current scientific evidence on the mechanisms of vitamin D absorption, with a focus on vitamin D absorption through the apical membrane of enterocytes in various pathologies of the gastrointestinal tract. Reviewed studies have identified some distinctive aspects of vitamin D bioavailability that should be considered in the treatment or prevention of vitamin D deficiency in patients with malabsorption syndromes, especially in the active phase of the disease. Moreover, recent in vivo experiments and in vitro studies have demonstrated that vitamin D absorption is not a simple diffusion process as previously thought, but rather a mechanism that also involves multiple membrane transporters. Maintaining or improving vitamin D intake through diet or increased sun exposure is problematic, so oral supplementation may be an effective and safe approach to improving vitamin D status. Vitamin D3 is the recommended form for both prevention and treatment of vitamin D deficiency, which is associated with more stable pharmacokinetics. Vitamin D absorption is improved when vitamin D is taken with a small amount of fat-containing food and medium chain triglycerides. In malabsorption syndromes, it is optimal to increase the general population doses of vitamin D by 2–3 times both for prevention and for the treatment of deficiency and insufficiency. While vitamin D deficiency is more common among people with gastrointestinal disease, data have not been able to establish whether the relationship is causal or the result of intestinal inflammation and malabsorption syndrome. However, owing to the understanding of the mechanisms of action of vitamin D, there is evidence that its deficiency can be directly related to the severity of the disease, and partly to the etiology or pathogenesis of the disease itself. cholecalciferol vitamin d medium chain triglycerides absorption malabsorption syndrome intestine vitaminkid3 Physiology Biochemistry L. К. Dzeranova verfasserin aut D. A. Yatsenko verfasserin aut In Ожирение и метаболизм 19(2022), 1, Seite 123-133 volume:19 year:2022 number:1 pages:123-133 https://doi.org/10.14341/omet12835 kostenfrei https://doaj.org/article/ce55a423258d41a4b6d1bfcebd9ca184 kostenfrei https://www.omet-endojournals.ru/jour/article/view/12835 kostenfrei https://doaj.org/toc/2071-8713 Journal toc kostenfrei https://doaj.org/toc/2306-5524 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 19 2022 1 123-133 |
| allfieldsGer |
10.14341/omet12835 doi (DE-627)DOAJ034236430 (DE-599)DOAJce55a423258d41a4b6d1bfcebd9ca184 DE-627 ger DE-627 rakwb eng rus QP1-981 QD415-436 E. A. Pigarova verfasserin aut Absorption and metabolism of vitamin D in health and in gastrointestinal tract diseases 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Over the past decades, we have witnessed many remarkable advances in understanding the impact of vitamin D on human health. There is an exponential growth of new data covering both the fundamental biology of vitamin D and the clinical implications of deficiency and the effects of vitamin D supplementation. This literature review has been prepared to combine and interpret the current scientific evidence on the mechanisms of vitamin D absorption, with a focus on vitamin D absorption through the apical membrane of enterocytes in various pathologies of the gastrointestinal tract. Reviewed studies have identified some distinctive aspects of vitamin D bioavailability that should be considered in the treatment or prevention of vitamin D deficiency in patients with malabsorption syndromes, especially in the active phase of the disease. Moreover, recent in vivo experiments and in vitro studies have demonstrated that vitamin D absorption is not a simple diffusion process as previously thought, but rather a mechanism that also involves multiple membrane transporters. Maintaining or improving vitamin D intake through diet or increased sun exposure is problematic, so oral supplementation may be an effective and safe approach to improving vitamin D status. Vitamin D3 is the recommended form for both prevention and treatment of vitamin D deficiency, which is associated with more stable pharmacokinetics. Vitamin D absorption is improved when vitamin D is taken with a small amount of fat-containing food and medium chain triglycerides. In malabsorption syndromes, it is optimal to increase the general population doses of vitamin D by 2–3 times both for prevention and for the treatment of deficiency and insufficiency. While vitamin D deficiency is more common among people with gastrointestinal disease, data have not been able to establish whether the relationship is causal or the result of intestinal inflammation and malabsorption syndrome. However, owing to the understanding of the mechanisms of action of vitamin D, there is evidence that its deficiency can be directly related to the severity of the disease, and partly to the etiology or pathogenesis of the disease itself. cholecalciferol vitamin d medium chain triglycerides absorption malabsorption syndrome intestine vitaminkid3 Physiology Biochemistry L. К. Dzeranova verfasserin aut D. A. Yatsenko verfasserin aut In Ожирение и метаболизм 19(2022), 1, Seite 123-133 volume:19 year:2022 number:1 pages:123-133 https://doi.org/10.14341/omet12835 kostenfrei https://doaj.org/article/ce55a423258d41a4b6d1bfcebd9ca184 kostenfrei https://www.omet-endojournals.ru/jour/article/view/12835 kostenfrei https://doaj.org/toc/2071-8713 Journal toc kostenfrei https://doaj.org/toc/2306-5524 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 19 2022 1 123-133 |
| allfieldsSound |
10.14341/omet12835 doi (DE-627)DOAJ034236430 (DE-599)DOAJce55a423258d41a4b6d1bfcebd9ca184 DE-627 ger DE-627 rakwb eng rus QP1-981 QD415-436 E. A. Pigarova verfasserin aut Absorption and metabolism of vitamin D in health and in gastrointestinal tract diseases 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Over the past decades, we have witnessed many remarkable advances in understanding the impact of vitamin D on human health. There is an exponential growth of new data covering both the fundamental biology of vitamin D and the clinical implications of deficiency and the effects of vitamin D supplementation. This literature review has been prepared to combine and interpret the current scientific evidence on the mechanisms of vitamin D absorption, with a focus on vitamin D absorption through the apical membrane of enterocytes in various pathologies of the gastrointestinal tract. Reviewed studies have identified some distinctive aspects of vitamin D bioavailability that should be considered in the treatment or prevention of vitamin D deficiency in patients with malabsorption syndromes, especially in the active phase of the disease. Moreover, recent in vivo experiments and in vitro studies have demonstrated that vitamin D absorption is not a simple diffusion process as previously thought, but rather a mechanism that also involves multiple membrane transporters. Maintaining or improving vitamin D intake through diet or increased sun exposure is problematic, so oral supplementation may be an effective and safe approach to improving vitamin D status. Vitamin D3 is the recommended form for both prevention and treatment of vitamin D deficiency, which is associated with more stable pharmacokinetics. Vitamin D absorption is improved when vitamin D is taken with a small amount of fat-containing food and medium chain triglycerides. In malabsorption syndromes, it is optimal to increase the general population doses of vitamin D by 2–3 times both for prevention and for the treatment of deficiency and insufficiency. While vitamin D deficiency is more common among people with gastrointestinal disease, data have not been able to establish whether the relationship is causal or the result of intestinal inflammation and malabsorption syndrome. However, owing to the understanding of the mechanisms of action of vitamin D, there is evidence that its deficiency can be directly related to the severity of the disease, and partly to the etiology or pathogenesis of the disease itself. cholecalciferol vitamin d medium chain triglycerides absorption malabsorption syndrome intestine vitaminkid3 Physiology Biochemistry L. К. Dzeranova verfasserin aut D. A. Yatsenko verfasserin aut In Ожирение и метаболизм 19(2022), 1, Seite 123-133 volume:19 year:2022 number:1 pages:123-133 https://doi.org/10.14341/omet12835 kostenfrei https://doaj.org/article/ce55a423258d41a4b6d1bfcebd9ca184 kostenfrei https://www.omet-endojournals.ru/jour/article/view/12835 kostenfrei https://doaj.org/toc/2071-8713 Journal toc kostenfrei https://doaj.org/toc/2306-5524 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 19 2022 1 123-133 |
| language |
English Russian |
| source |
In Ожирение и метаболизм 19(2022), 1, Seite 123-133 volume:19 year:2022 number:1 pages:123-133 |
| sourceStr |
In Ожирение и метаболизм 19(2022), 1, Seite 123-133 volume:19 year:2022 number:1 pages:123-133 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
cholecalciferol vitamin d medium chain triglycerides absorption malabsorption syndrome intestine vitaminkid3 Physiology Biochemistry |
| isfreeaccess_bool |
true |
| container_title |
Ожирение и метаболизм |
| authorswithroles_txt_mv |
E. A. Pigarova @@aut@@ L. К. Dzeranova @@aut@@ D. A. Yatsenko @@aut@@ |
| publishDateDaySort_date |
2022-01-01T00:00:00Z |
| id |
DOAJ034236430 |
| language_de |
englisch russisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ034236430</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240413141250.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.14341/omet12835</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ034236430</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJce55a423258d41a4b6d1bfcebd9ca184</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QP1-981</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QD415-436</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">E. A. Pigarova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Absorption and metabolism of vitamin D in health and in gastrointestinal tract diseases</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Over the past decades, we have witnessed many remarkable advances in understanding the impact of vitamin D on human health. There is an exponential growth of new data covering both the fundamental biology of vitamin D and the clinical implications of deficiency and the effects of vitamin D supplementation. This literature review has been prepared to combine and interpret the current scientific evidence on the mechanisms of vitamin D absorption, with a focus on vitamin D absorption through the apical membrane of enterocytes in various pathologies of the gastrointestinal tract. Reviewed studies have identified some distinctive aspects of vitamin D bioavailability that should be considered in the treatment or prevention of vitamin D deficiency in patients with malabsorption syndromes, especially in the active phase of the disease. Moreover, recent in vivo experiments and in vitro studies have demonstrated that vitamin D absorption is not a simple diffusion process as previously thought, but rather a mechanism that also involves multiple membrane transporters. Maintaining or improving vitamin D intake through diet or increased sun exposure is problematic, so oral supplementation may be an effective and safe approach to improving vitamin D status. Vitamin D3 is the recommended form for both prevention and treatment of vitamin D deficiency, which is associated with more stable pharmacokinetics. Vitamin D absorption is improved when vitamin D is taken with a small amount of fat-containing food and medium chain triglycerides. In malabsorption syndromes, it is optimal to increase the general population doses of vitamin D by 2–3 times both for prevention and for the treatment of deficiency and insufficiency. While vitamin D deficiency is more common among people with gastrointestinal disease, data have not been able to establish whether the relationship is causal or the result of intestinal inflammation and malabsorption syndrome. However, owing to the understanding of the mechanisms of action of vitamin D, there is evidence that its deficiency can be directly related to the severity of the disease, and partly to the etiology or pathogenesis of the disease itself.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">cholecalciferol</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">vitamin d</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">medium chain triglycerides</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">absorption</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">malabsorption syndrome</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">intestine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">vitaminkid3</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Physiology</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Biochemistry</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">L. К. Dzeranova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">D. A. Yatsenko</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Ожирение и метаболизм</subfield><subfield code="g">19(2022), 1, Seite 123-133</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:19</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:123-133</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.14341/omet12835</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/ce55a423258d41a4b6d1bfcebd9ca184</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.omet-endojournals.ru/jour/article/view/12835</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2071-8713</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2306-5524</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">19</subfield><subfield code="j">2022</subfield><subfield code="e">1</subfield><subfield code="h">123-133</subfield></datafield></record></collection>
|
| callnumber-first |
Q - Science |
| author |
E. A. Pigarova |
| spellingShingle |
E. A. Pigarova misc QP1-981 misc QD415-436 misc cholecalciferol misc vitamin d misc medium chain triglycerides misc absorption misc malabsorption syndrome misc intestine misc vitaminkid3 misc Physiology misc Biochemistry Absorption and metabolism of vitamin D in health and in gastrointestinal tract diseases |
| authorStr |
E. A. Pigarova |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut |
| collection |
DOAJ |
| remote_str |
true |
| callnumber-label |
QP1-981 |
| illustrated |
Not Illustrated |
| topic_title |
QP1-981 QD415-436 Absorption and metabolism of vitamin D in health and in gastrointestinal tract diseases cholecalciferol vitamin d medium chain triglycerides absorption malabsorption syndrome intestine vitaminkid3 |
| topic |
misc QP1-981 misc QD415-436 misc cholecalciferol misc vitamin d misc medium chain triglycerides misc absorption misc malabsorption syndrome misc intestine misc vitaminkid3 misc Physiology misc Biochemistry |
| topic_unstemmed |
misc QP1-981 misc QD415-436 misc cholecalciferol misc vitamin d misc medium chain triglycerides misc absorption misc malabsorption syndrome misc intestine misc vitaminkid3 misc Physiology misc Biochemistry |
| topic_browse |
misc QP1-981 misc QD415-436 misc cholecalciferol misc vitamin d misc medium chain triglycerides misc absorption misc malabsorption syndrome misc intestine misc vitaminkid3 misc Physiology misc Biochemistry |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Ожирение и метаболизм |
| hierarchy_top_title |
Ожирение и метаболизм |
| isfreeaccess_txt |
true |
| title |
Absorption and metabolism of vitamin D in health and in gastrointestinal tract diseases |
| ctrlnum |
(DE-627)DOAJ034236430 (DE-599)DOAJce55a423258d41a4b6d1bfcebd9ca184 |
| title_full |
Absorption and metabolism of vitamin D in health and in gastrointestinal tract diseases |
| author_sort |
E. A. Pigarova |
| journal |
Ожирение и метаболизм |
| journalStr |
Ожирение и метаболизм |
| callnumber-first-code |
Q |
| lang_code |
eng rus |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2022 |
| contenttype_str_mv |
txt |
| container_start_page |
123 |
| author_browse |
E. A. Pigarova L. К. Dzeranova D. A. Yatsenko |
| container_volume |
19 |
| class |
QP1-981 QD415-436 |
| format_se |
Elektronische Aufsätze |
| author-letter |
E. A. Pigarova |
| doi_str_mv |
10.14341/omet12835 |
| author2-role |
verfasserin |
| title_sort |
absorption and metabolism of vitamin d in health and in gastrointestinal tract diseases |
| callnumber |
QP1-981 |
| title_auth |
Absorption and metabolism of vitamin D in health and in gastrointestinal tract diseases |
| abstract |
Over the past decades, we have witnessed many remarkable advances in understanding the impact of vitamin D on human health. There is an exponential growth of new data covering both the fundamental biology of vitamin D and the clinical implications of deficiency and the effects of vitamin D supplementation. This literature review has been prepared to combine and interpret the current scientific evidence on the mechanisms of vitamin D absorption, with a focus on vitamin D absorption through the apical membrane of enterocytes in various pathologies of the gastrointestinal tract. Reviewed studies have identified some distinctive aspects of vitamin D bioavailability that should be considered in the treatment or prevention of vitamin D deficiency in patients with malabsorption syndromes, especially in the active phase of the disease. Moreover, recent in vivo experiments and in vitro studies have demonstrated that vitamin D absorption is not a simple diffusion process as previously thought, but rather a mechanism that also involves multiple membrane transporters. Maintaining or improving vitamin D intake through diet or increased sun exposure is problematic, so oral supplementation may be an effective and safe approach to improving vitamin D status. Vitamin D3 is the recommended form for both prevention and treatment of vitamin D deficiency, which is associated with more stable pharmacokinetics. Vitamin D absorption is improved when vitamin D is taken with a small amount of fat-containing food and medium chain triglycerides. In malabsorption syndromes, it is optimal to increase the general population doses of vitamin D by 2–3 times both for prevention and for the treatment of deficiency and insufficiency. While vitamin D deficiency is more common among people with gastrointestinal disease, data have not been able to establish whether the relationship is causal or the result of intestinal inflammation and malabsorption syndrome. However, owing to the understanding of the mechanisms of action of vitamin D, there is evidence that its deficiency can be directly related to the severity of the disease, and partly to the etiology or pathogenesis of the disease itself. |
| abstractGer |
Over the past decades, we have witnessed many remarkable advances in understanding the impact of vitamin D on human health. There is an exponential growth of new data covering both the fundamental biology of vitamin D and the clinical implications of deficiency and the effects of vitamin D supplementation. This literature review has been prepared to combine and interpret the current scientific evidence on the mechanisms of vitamin D absorption, with a focus on vitamin D absorption through the apical membrane of enterocytes in various pathologies of the gastrointestinal tract. Reviewed studies have identified some distinctive aspects of vitamin D bioavailability that should be considered in the treatment or prevention of vitamin D deficiency in patients with malabsorption syndromes, especially in the active phase of the disease. Moreover, recent in vivo experiments and in vitro studies have demonstrated that vitamin D absorption is not a simple diffusion process as previously thought, but rather a mechanism that also involves multiple membrane transporters. Maintaining or improving vitamin D intake through diet or increased sun exposure is problematic, so oral supplementation may be an effective and safe approach to improving vitamin D status. Vitamin D3 is the recommended form for both prevention and treatment of vitamin D deficiency, which is associated with more stable pharmacokinetics. Vitamin D absorption is improved when vitamin D is taken with a small amount of fat-containing food and medium chain triglycerides. In malabsorption syndromes, it is optimal to increase the general population doses of vitamin D by 2–3 times both for prevention and for the treatment of deficiency and insufficiency. While vitamin D deficiency is more common among people with gastrointestinal disease, data have not been able to establish whether the relationship is causal or the result of intestinal inflammation and malabsorption syndrome. However, owing to the understanding of the mechanisms of action of vitamin D, there is evidence that its deficiency can be directly related to the severity of the disease, and partly to the etiology or pathogenesis of the disease itself. |
| abstract_unstemmed |
Over the past decades, we have witnessed many remarkable advances in understanding the impact of vitamin D on human health. There is an exponential growth of new data covering both the fundamental biology of vitamin D and the clinical implications of deficiency and the effects of vitamin D supplementation. This literature review has been prepared to combine and interpret the current scientific evidence on the mechanisms of vitamin D absorption, with a focus on vitamin D absorption through the apical membrane of enterocytes in various pathologies of the gastrointestinal tract. Reviewed studies have identified some distinctive aspects of vitamin D bioavailability that should be considered in the treatment or prevention of vitamin D deficiency in patients with malabsorption syndromes, especially in the active phase of the disease. Moreover, recent in vivo experiments and in vitro studies have demonstrated that vitamin D absorption is not a simple diffusion process as previously thought, but rather a mechanism that also involves multiple membrane transporters. Maintaining or improving vitamin D intake through diet or increased sun exposure is problematic, so oral supplementation may be an effective and safe approach to improving vitamin D status. Vitamin D3 is the recommended form for both prevention and treatment of vitamin D deficiency, which is associated with more stable pharmacokinetics. Vitamin D absorption is improved when vitamin D is taken with a small amount of fat-containing food and medium chain triglycerides. In malabsorption syndromes, it is optimal to increase the general population doses of vitamin D by 2–3 times both for prevention and for the treatment of deficiency and insufficiency. While vitamin D deficiency is more common among people with gastrointestinal disease, data have not been able to establish whether the relationship is causal or the result of intestinal inflammation and malabsorption syndrome. However, owing to the understanding of the mechanisms of action of vitamin D, there is evidence that its deficiency can be directly related to the severity of the disease, and partly to the etiology or pathogenesis of the disease itself. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ |
| container_issue |
1 |
| title_short |
Absorption and metabolism of vitamin D in health and in gastrointestinal tract diseases |
| url |
https://doi.org/10.14341/omet12835 https://doaj.org/article/ce55a423258d41a4b6d1bfcebd9ca184 https://www.omet-endojournals.ru/jour/article/view/12835 https://doaj.org/toc/2071-8713 https://doaj.org/toc/2306-5524 |
| remote_bool |
true |
| author2 |
L. К. Dzeranova D. A. Yatsenko |
| author2Str |
L. К. Dzeranova D. A. Yatsenko |
| callnumber-subject |
QP - Physiology |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.14341/omet12835 |
| callnumber-a |
QP1-981 |
| up_date |
2024-07-03T22:09:13.157Z |
| _version_ |
1803597437381640192 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ034236430</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240413141250.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.14341/omet12835</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ034236430</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJce55a423258d41a4b6d1bfcebd9ca184</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QP1-981</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QD415-436</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">E. A. Pigarova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Absorption and metabolism of vitamin D in health and in gastrointestinal tract diseases</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Over the past decades, we have witnessed many remarkable advances in understanding the impact of vitamin D on human health. There is an exponential growth of new data covering both the fundamental biology of vitamin D and the clinical implications of deficiency and the effects of vitamin D supplementation. This literature review has been prepared to combine and interpret the current scientific evidence on the mechanisms of vitamin D absorption, with a focus on vitamin D absorption through the apical membrane of enterocytes in various pathologies of the gastrointestinal tract. Reviewed studies have identified some distinctive aspects of vitamin D bioavailability that should be considered in the treatment or prevention of vitamin D deficiency in patients with malabsorption syndromes, especially in the active phase of the disease. Moreover, recent in vivo experiments and in vitro studies have demonstrated that vitamin D absorption is not a simple diffusion process as previously thought, but rather a mechanism that also involves multiple membrane transporters. Maintaining or improving vitamin D intake through diet or increased sun exposure is problematic, so oral supplementation may be an effective and safe approach to improving vitamin D status. Vitamin D3 is the recommended form for both prevention and treatment of vitamin D deficiency, which is associated with more stable pharmacokinetics. Vitamin D absorption is improved when vitamin D is taken with a small amount of fat-containing food and medium chain triglycerides. In malabsorption syndromes, it is optimal to increase the general population doses of vitamin D by 2–3 times both for prevention and for the treatment of deficiency and insufficiency. While vitamin D deficiency is more common among people with gastrointestinal disease, data have not been able to establish whether the relationship is causal or the result of intestinal inflammation and malabsorption syndrome. However, owing to the understanding of the mechanisms of action of vitamin D, there is evidence that its deficiency can be directly related to the severity of the disease, and partly to the etiology or pathogenesis of the disease itself.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">cholecalciferol</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">vitamin d</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">medium chain triglycerides</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">absorption</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">malabsorption syndrome</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">intestine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">vitaminkid3</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Physiology</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Biochemistry</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">L. К. Dzeranova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">D. A. Yatsenko</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Ожирение и метаболизм</subfield><subfield code="g">19(2022), 1, Seite 123-133</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:19</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:123-133</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.14341/omet12835</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/ce55a423258d41a4b6d1bfcebd9ca184</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.omet-endojournals.ru/jour/article/view/12835</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2071-8713</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2306-5524</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">19</subfield><subfield code="j">2022</subfield><subfield code="e">1</subfield><subfield code="h">123-133</subfield></datafield></record></collection>
|
| score |
7.399824 |